Catch Up on the Status Quo of OTC market reforms in Asia

Catch Up on the Status Quo of OTC market reforms in Asia.

5 Responses to “Catch Up on the Status Quo of OTC market reforms in Asia”

  1. This report seems to miss out South Korea and India and Shanghai, China all of which had some considerable activities as of last summer.

  2. You can email the author at the bottom of his piece…

  3. Bill,

    Thanks for this post.

    FYI – I come out with a regular newsletter covering the OTC regulatory reform developments across APAC which can be accessed for free at ->

    http://www.ey.com/CN/en/Industries/Financial-Services/OTC-Derivatives-newsletter.

    Happy to respond to any specific questions you may have on the APAC OTC reform measures.

    Kishore

  4. Reblogged this on Carl A R Weir's Blog and commented:
    This is a really good, by-country breakdown.

  5. First of all, thanks a lot for the interest in our research and the active feedback. The jurisdictions that we highlighted, Australia, Hong Kong, Japan and Singapore, represent approximately 20% of the global OTC derivative market and can therefore be considered global key players. Other regions, like India or Korea, are highly interesting but considerably smaller in volume, representing less than 1% of the global OTC turnover respectively. For our market commentary we decided to focus on the larger markets that are impacted by the OTC market reform. Hope that clarifies things.

    Sendi Cigura

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s

%d bloggers like this: